Advanced search
Publication Cover
Cancer Investigation Volume 19, 2001 - Issue 3
Submit an article Journal homepage
22
Views
1
CrossRef citations to date
0
Altmetric
Original

A Phase II Study of Weekly Alternating Chemotherapy in Extensive-Stage Small Cell Lung Cancer

Gregory P. Kalemkerian Department of Medicine, Division of Hematology and Oncology, Wayne State University, Detroit, Michigan, U.S.A.; 1366 Cancer Center 0922, 1500 E. Medical Center Dr., Ann Arbor, MI, University of Michigan Medical Center, 48109-0922
, M.D.,
Muhammad A. Ali Department of Medicine, Division of Hematology and Oncology, Wayne State University, Detroit, Michigan, U.S.A.
, M.D.,
Kavita Luthra Department of Medicine, Division of Hematology and Oncology, Wayne State University, Detroit, Michigan, U.S.A.
, M.D.,
Antoinette J. Wozniak Department of Medicine, Division of Hematology and Oncology, Wayne State University, Detroit, Michigan, U.S.A.
, M.D.,
Manuel Valdivieso Department of Medicine, Division of Hematology and Oncology, Wayne State University, Detroit, Michigan, U.S.A.
, M.D. &
Michael J. Kraut Department of Medicine, Division of Hematology and Oncology, Wayne State University, Detroit, Michigan, U.S.A.
, M.D.
Pages 234-238 | Published online: 31 Mar 2001

REFERENCES

  • Ihde D. C. Small Cell Lung Cancer: State of the Art Therapy 1994. Chest 1995; 107: 243S–248S
  • Lassen U. N., Hirsch F. R., Østerlind K., Bergman B., Dombernowsky P. Outcome of Combination Chemotherapy in Extensive Stage Small-Cell Lung Cancer: Any Treatment Related Progress?. Lung Cancer 1998; 20: 151–160
  • Shepard F. The Role of Chemotherapy in the Treatment of Small Cell Lung Cancer. Chest Surg. Clin. North Am 1997; 7: 113–133
  • Sandler A. B. Current Management of Small Cell Lung Cancer. Semin. Oncol. 1997; 24: 463–476
  • Valdivieso M., Wozniak A., Flaherty L., Pazdur R., Herskovic A., Heilbrun L., Redman B., Martino S., Baker L. Efficacy of Weekly Chemotherapy for Small Cell Lung Cancer. Proc. Am. Soc. Clin. Oncol. 1990; 9: 238
  • Goldie J. H., Coldman A. J. A Mathematical Model for Relating Sensitivity of Tumors to Their Spontaneous Mutation Rate. Cancer Treat. Rep. 1979; 63: 1727–1733
  • Evans W. K., Feld R., Murray N., Willan A., Coy P., Osoba D., Shepard F. A., Clark D. A., Levitt M., MacDonald A., Wilson K., Shelley W., Pater J. Superiority of Alternating Non-Cross-Resistant Chemotherapy in Extensive Small Cell Lung Cancer: A Multicenter Randomized Clinical Trial by the National Cancer Institute of Canada. Ann. Int. Med. 1987; 107: 451–458
  • Fukuoka M., Furuse K., Saijo N., Nishiwaki Y., Ikegami H., Tamura T., Shimoyama M., Suemasa K. Randomized Trial of Cyclophosphamide, Doxorubicin and Vincristine Versus Etoposide and Cisplatin Versus Alternation of These Two Regimens in Small Cell Lung Cancer. J. Natl. Cancer Inst. 1991; 83: 855–861
  • Roth B. J., Johnson D. H., Einhorn L. H., Schacter L. P., Cherng N. C., Cohen H. J., Crawford J., Randolph J. A., Goodlow J. L., Broun G. O., Omura G. A., Greco F. A. Randomized Study of Cyclophosphamide, Doxorubicin and Vincristine Versus Etoposide and Cisplatin Versus Alternation of These Two Regimens in Extensive Small-Cell Lung Cancer; a Phase III trial of the Southeastern Cancer Study Group. J. Clin. Oncol. 1992; 10: 282–291
  • Murray N., Shah A., Osoba D., Page R., Karsai H., Grafton C., Goddard K., Fairey R., Voss N. Intensive Weekly Chemotherapy for the Treatment of Extensive-Stage Small-Cell Lung Cancer. J. Clin. Oncol. 1991; 9: 1632–1638
  • Furuse K., Fukuoka M., Nishiwaki Y., Kurita Y., Watanabe K., Noda K., Ariyoshi Y., Tamura T., Saijo N. Phase III Study of Intensive Weekly Chemotherapy with Recombinant Human Granulocyte Colony-Stimulating Factor Versus Standard Chemotherapy in Extensive-Disease Small-Cell Lung Cancer. J. Clin. Oncol. 1998; 6: 2126–2132
  • Taylor C. W., Crowley J., Williamson S. K., Miller T. P., Taylor S. A., Shanker T. G. Giri, Stephens R. L., Livingston R. B. Treatment of Small Cell Lung Cancer with an Alternating Chemotherapy Regimen Given at Weekly Intervals: A Southwest Oncology Group Pilot Study. J. Clin. Oncol. 1990; 8: 1811–1817
  • Miles D. W., Earl H. M., Souhami R. L., Harper P. G., Rudd R., Ash C. M., James L., Trask C. W.L., Tobias J. S., Spiro S. G. Intensive Weekly Chemotherapy for Good-Prognosis Patients with Small-Cell Lung Cancer. J. Clin. Oncol. 1991; 9: 280–285
  • Souhami R. L., Rudd R., Ruiz de Elvira M.-C., Gower J. N., Harper P. G., Tobias J. S., Partridge M. R., Davison A. G., Trask C., Spiro S. G. Randomized Trial Comparing Weekly versus 3-Week Chemotherapy in Small-Cell Lung Cancer: A Cancer Research Campaign Trial. J. Clin. Oncol. 1994; 12: 1806–1813
  • Sculier J. P., Paesmans M., Bureau G., Dabouis G., Libert P., Vandermoten G., Van Cutsem O., Berchier M. C., Ries F., Michel J., Sergysels R., Mommen P., Klastersky J. Multiple-Day Weekly Chemotherapy Versus Standard Combination Regimens in Small Cell Lung Cancer: A Phase III Randomized Study Conducted by the European Lung Cancer Working Party. J. Clin. Oncol. 1993; 11: 1858–1865

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.